COVID-19 convalescent plasma no real help to at-risk ED patients, study confirms

Aug 19, 2021 - 02:34 PM
COVID19 Web Sized

In a federally funded study that enrolled more than 500 patients from U.S. hospital emergency departments, administering COVID-19 convalescent plasma to high-risk COVID-19 outpatients with early symptoms did not prevent disease progression, according to final results reported yesterday in the New England Journal of Medicine. Funded by the National Institutes of Health and Biomedical Advanced Research and Development Authority, the clinical trial was halted in February after an independent board concluded that the treatment was unlikely to help such patients. 

“We were hoping that the use of COVID-19 convalescent plasma would achieve at least a 10% reduction in disease progression in this group, but instead the reduction we observed was less than 2%,” said Clifton Callaway, M.D., principal investigator and professor of emergency medicine at the University of Pittsburgh.
 

Related News Articles

Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
CDC data shows rise in flu, COVID-19 cases across states 
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
Study finds flu, COVID-19 infection temporarily raises risk of heart attack, stroke 
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…